Polydeoxyribonucleotides clinical trials
How each study uses Polydeoxyribonucleotides is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Polydeoxyribonucleotides studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 5
Chuncheon Sacred Heart Hospital (2) · University of Messina (1) · Misr University for Science and Technology (1) · Mastelli S.r.l (1) · Seoul National University Hospital (1)
Studies
Open first, then newest update. How each study uses Polydeoxyribonucleotides is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional CO₂ LaserRecruitingPhase 2Misr University for Science and TechnologyNCT07472192Written as Polydeoxyribonucleotide
- Polydeoxyribonucleotide for Elbow Lateral EpicondylitisCompletedNot applicableChuncheon Sacred Heart HospitalNCT06753630Written as Polydeoxyribonucleotide Injection
- Polydeoxyribonucleotide (PDRN) for Cuff RegenerationCompletedPhase 4Chuncheon Sacred Heart HospitalNCT03916198Written as Polydeoxyribonucleotides
- Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma DiseasesTerminatedPhase 4Mastelli S.r.lNCT03388255Written as Polydeoxyribonucleotides
- Effects and Safety of Epidural PDRN vs. PlaceboStatus unknownPhase 4Seoul National University HospitalNCT04401735Written as Polydeoxyribonucleotides
- Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic UlcersCompletedPhase 4University of MessinaNCT00638872Written as Polydeoxyribonucleotide